<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Pacira BioSciences, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Pacira BioSciences, Inc.

    Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoamÂŽ drug delivery technology, for use in hospitals and ambulatory surgery centers. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $120,600,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David Stack
    • FOUNDED
      1989
    • EMPLOYEES
      501-1000
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Nemaura Medical Inc.

    Nemaura Medical Inc.

    Nemaura Medical (NASDAQ:NMRD) is a medical technology company which has developed ...

    Nemaura Medical (NASDAQ:NMRD) is a medical tech...

    Filing Type:    PU
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Correvio Pharma Corp.

    Correvio Pharma Corp.

    Correvio has two marketed, in-hospital, cardiology products: BRINAVESSÂŽ (vernakal...

    Correvio has two marketed, in-hospital, cardiol...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.